Videos

WATCH: Israeli drug doubles survival time for patients with brain tumors

Professor Dror Harats, M.D., CEO of VBL Therapeutics, describes Phase III clinical trials of a cancer treatment in which a virus is injected intravenously and cuts off blood supply to solid tumors, shrinking cancerous growths.

Share
Published by
Eliyahu Tulshinski
Tags: brain tumors cancer treatment Dror Harats solid tumors VBL Therapeutics virus

Recent Posts

  • Arab-Israeli Conflict

Hamas quietly rebuilding its terror tunnel networks – report

Israeli security officials warn that with IDF's attention focused on Iran, Hamas is rebuilding its…

19 minutes ago
  • Jewish Diaspora & Antisemitism

Trump expresses alarm at growing US antisemitism, compares situation to Nazi Germany

President Trump expresses alarm at the extent of antisemitism in the US, vows to fight…

1 hour ago
  • Israel News

Bringing Islamist party into gov’t could threaten Israel’s national security, defense minister warns

Defense Minister Israel Katz warns against Israeli-Arab party joining next government, citing Muslim Brotherhood's ties…

2 hours ago
  • WhatsApp Brief

Netanyahu’s office investigated over alleged plot to discredit Israel’s election results

Israeli authorities are investigating whether Prime Minister Benjamin Netanyahu’s office orchestrated election-day arrests to undermine…

4 hours ago
  • Israel News

Knesset member calls for changing Israel’s national anthem because it’s ‘Zionist’

Originally adopted by the Zionist movement, 'Hatikvah' expresses the Jewish people’s enduring hope for freedom…

12 hours ago
  • World News

USS Theodore Roosevelt to join two US aircraft carriers in Middle East as talks fail

American and Israeli officials have prepared plans for renewed strikes on Iran’s economic infrastructure.

13 hours ago